Mercury Bio is a biomolecular delivery platform that transforms and treats viral diseases, cancer, and inflammatory conditions.
Mercury Bio has raised $2.4M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2025.
Mercury Bio's investors include New Mexico Economic Development Department.
Mercury Bio is headquartered in Santa Fe, United States.
Mercury Bio is a biomolecular delivery platform that transforms and treats viral diseases, cancer, and inflammatory conditions.
Mercury Bio is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Mercury Bio — Funding & Investors." VCBacked, October 24, 2025, https://www.vcbacked.co/company/mercury-bio. Accessed September 30, 2026.
VCBacked. (2025). Mercury Bio — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/mercury-bio
{{cite web |title=Mercury Bio — Funding & Investors |url=https://www.vcbacked.co/company/mercury-bio |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated